PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Wankdorfstrasse 10, 3014 Bern, Switzerland.\', \'Assay Design, Thermo Fisher Scientific ImmunoDiagnostics Phadia GmbH, Munzinger Strasse 7, 79111 Freiburg, Germany.\', \'Laboratory Operations, CSL Plasma, 1001 Corridor Park Blvd., Knoxville, TN 37932, USA.\', \'Pharmaceutical Analysis and Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring Innovation GmbH, P.O. Box 1230, 35002 Marburg, Germany.\', \'Plasma and Plasma Safety, CSL Plasma, 900 Broken Sound Parkway, Suite 400, Boca Raton, FL 33487, USA.\', \'Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Wankdorfstrasse 10, 3014 Bern, Switzerland. Electronic address: Patrick.Schuetz@cslbehring.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1521-6616(21)00208-410.1016/j.clim.2021.108871
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 34619377
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34619377>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34619377>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all